ABSTRACT
MATERIALS AND METHODS

Isolation of human NK precursors from SLT
All procedures were approved by The OSU Institutional Review Board. NK developmental intermediates were isolated from fresh normal tonsil and analyzed as described by Freud et al (2) . All populations were sorted to purity >99%.
cDNA preparation
RNA was purified from < 5 x 10 5 NK cells using Absolutely RNA Nanoprep Kit (Stratagene) or using RNeasy (Qiagen) if > 5x10 5 . cDNA was synthesized using MMLV reverse transcriptase kit (Invitrogen) and random hexamers.
Real-Time PCR
Taqman primer/probe sets for IL-22, IL-26, IL-17A, and IL-17F were purchased from ABI (Applied Biosystems). Real-Time PCR was performed on an ABI Prism 7900HT, analyzed by the ΔΔCt method, and normalized to an 18S internal control.
Flow cytometric analyses
Total CD3(-)CD19(-)CD34(-) tonsillar mononuclear cells were isolated as previously described (2 . Non-specific staining was detected through the use of an appropriately labeled isotype control mAB in all analyses. Cytometric and data analyses were performed as previously described (1).
Statistical analysis
Data were analyzed using a Student 2-tailed t-test. P < 0.05 was considered significant. We detected IL-22 protein in stage three resting iNK cells using intracellular staining with an anti-IL-22 antibody. The majority of CD117(+)CD94(-) stage three iNK cells, a population previously described in our lab as NKp46(-)2B4(+) (2), co-express intracellular IL-22, whereas staining is very low in the CD117(+/-)CD94(+) stage four population ( Figure 1B) . Indeed, 88.0 ± 5.3% of stage three iNK cells were IL-22(+) compared to 6.7 ± 3.5% of stage four NK cells ( Figure 1C ; P < 0.00002, n = 6;). We utilized an ELISA to confirm that resting and IL-15 stimulated stage three iNK cells, but not stage four NK cells, secrete IL-22 protein (not shown). Supplemental Figure 1 documents the localization of these cells to the lamina propria and parafollicular region of the tonsil.
We found that most CD117(+)CD94(-)IL-22(+) cells express CD161, but do not express BDCA-2, ruling out inclusion of NK dendritic cells (6) (Figure 2A ). Less than 3% of stage three iNK cells express CD56 and < 15% of stage three iNK cells express NKp44, two markers associated with the inducible NK-22 
